
|Articles|January 1, 2006
Formulary decision making might require some guidance
Seattle—With pharmaceutical costs being the fastest increasing component of healthcare costs, it is important that managed care executives adopt policies that use the best-available evidence to compare the benefits, risks and costs of drugs to include in their health plan formularies.
Advertisement
"Most health plans already devote significant attention and resources to formulary decisions," says Greg Simon, MD, MPH, a researcher at Group Health Cooperative. "It is our hope that formulary committees and other decision makers focus on important questions and ask for the right kinds of evidence."
According to Dr. Simon, the most important principles that MCOs can use to guide decisions that improve patient safety and lower costs include:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Researchers discover new pathway to fight liver inflammation
4
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
5





















